Results 11 to 20 of about 41,253 (155)
The role of passive immunization in the age of SARS-CoV-2: an update
European Journal of Medical Research, 2020 The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role
Johannes C. Fischer +19 more
doaj +1 more source
Frontiers in Microbiology, 2018 New therapies are needed to prevent and treat Clostridium difficile infection and to limit the rise in antibiotic resistance. Besides toxins, several surface components have been characterized as colonization factors and have been shown as immunogenic ...
Séverine Péchiné +3 more
doaj +1 more source
Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases
Emerging Infectious Diseases, 1999 Passive immunization with antibodies has been shown to prevent a wide variety of diseases. Recent advances in monoclonal antibody technology are enabling the development of new methods for passive immunization of mucosal surfaces.
Larry Zeitlin +2 more
doaj +1 more source
Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. [PDF]
PLoS ONE, 2014 OBJECTIVE: Acinetobacter baumannii is considered the prototypical example of a multi- or pan- drug-resistant bacterium. It has been increasingly implicated as a major cause of nosocomial and community-associated infections.
Weiwei Huang +10 more
doaj +1 more source
, 2021 Immediate protection of an animal can be achieved by passive immunization—the administration of preformed antibodies to a susceptible animal. These antibodies have historically been produced in hyperimmunized horses. The most widely employed are antitoxins directed against clostridia, such as tetanus or botulism, and snake venoms. Polyclonal antibodies
openaire +2 more sources
Human Vaccines & Immunotherapeutics, 2023 New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in ...
Catherine Weil-Olivier +7 more
doaj +1 more source
Frontiers in Neuroscience, 2018 Synucleinopathies represent a group of neurodegenerative disorders which are characterized by intracellular accumulation of aggregated α-synuclein. α-synuclein misfolding and oligomer formation is considered a major pathogenic trigger in these disorders.
Martin Kallab +8 more
doaj +1 more source
Strategies for active and passive pediatric RSV immunization
Therapeutic Advances in Vaccines and Immunotherapy, 2021 Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vaccines.
Katherine M. Eichinger +4 more
doaj +1 more source
PEMBERIAN IMUNISASI HEPATITIS B (PASIF) PADA BAYI YANG LAHIR DARI IBU HBsAg POSITIF
Indonesian Midwifery and Health Sciences Journal, 2021 Abstrak Latar Belakang: Berdasarkan data Dinas Kesehatan Kota Surabaya tercatat 748 bayi lahir dari ibu dengan HBsAg positif diseluruh wilayah puskesmas kota Surabaya.
Ramadhani A. K. S +2 more
doaj +1 more source
Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. [PDF]
PLoS ONE, 2011 Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are common causes of motor and cognitive deficits and are associated with the abnormal accumulation of alpha-synuclein (α-syn). This study investigated whether passive immunization with a novel
Eliezer Masliah +16 more
doaj +1 more source